Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects

被引:0
|
作者
Chan, Phyllis [1 ]
Mould, Diane R. [2 ]
AbuTarif, Malaz [1 ]
Wen, Jessica [3 ]
Chang, Mei-Hwei [4 ]
Emerick, Karan [5 ]
Reynolds, Laurie [1 ]
Bertz, Richard [1 ]
Bifano, Marc [1 ]
机构
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Project Res Inc, Phoenixville, PA USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Univ Connecticut, Hartford, CT 06112 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
W-64
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 50 条
  • [1] Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations
    Chan, Phyllis
    Mould, Diane R.
    Abu Tarif, Malaz
    Reynolds, Laurie
    LaCreta, Frank
    Bertz, Richard
    Bifano, Marc
    CLINICAL PHARMACOKINETICS, 2016, 55 (12) : 1559 - 1572
  • [2] Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations
    Phyllis Chan
    Diane R. Mould
    Malaz Abu Tarif
    Laurie Reynolds
    Frank LaCreta
    Richard Bertz
    Marc Bifano
    Clinical Pharmacokinetics, 2016, 55 : 1559 - 1572
  • [3] Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Dutasteride in Male Subjects with Androgenetic Alopecia
    Ferron-Brady, Geraldine
    Gubelin Harcha, Walter
    Barboza Martinez, Julia Maria
    Tsai, Tsen-Fang
    Barnes, Allison
    Chetty, Dushen
    Kawashima, Makoto
    Katsuoka, Kensei
    Tsuboi, Ryoji
    Fossler, Michael
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S42 - S44
  • [4] Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients
    Carrothers, Timothy J.
    Lagraauw, H. Maxime
    Lindbom, Lars
    Riccobene, Todd A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (02) : 99 - 105
  • [5] Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease
    Loprete, Luca
    Leuratti, Chiara
    Cattaneo, Carlo
    Thapar, Mita M.
    Farrell, Colm
    Sardina, Marco
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (05):
  • [6] Population Pharmacokinetic and Pharmacodynamic Analyses of Cedirogant in Healthy Subjects and Subjects with Moderate to Severe Psoriasis
    Maier, Corinna
    Eckert, Doerthe
    Laroux, Stephen
    Hew, Kinjal M.
    Suleiman, Ahmed
    Liu, Wei
    Mohamed, Mohamed-Eslam F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB75 - AB75
  • [7] Pharmacokinetic and pharmacodynamic considerations of general anesthesia in pediatric subjects
    Anderson, Brian J.
    Morse, James D.
    Hannam, Jacqueline A.
    Cortinez, L. Ignacio
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (04) : 279 - 295
  • [8] Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Crass, Ryan L.
    Smith, Brandon
    Adriaens, Sven
    Chapel, Sunny
    Langdon, Grant
    DRUGS IN R&D, 2024, 24 (04) : 563 - 573
  • [9] Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza
    Zuo, Peiying
    Collins, Jon
    Okour, Malek
    Barth, Aline
    Shortino, Denise
    Yates, Phillip
    Roberts, Grace
    Watson, Helen A.
    Peppercorn, Amanda
    Hossain, Mohammad
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 157 - 168
  • [10] Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models
    Rosner, GL
    Muller, P
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (02): : 209 - 233